Press Releases

GENESIS Pharma, a leading regional biopharma company operating in the broader region of Southeast Europe, announced their exclusive agreement with Seagen Inc, a global biotechnology company that discovers, develops, and commercializes transformative cancer medicines, for the commercialization of an innovative, new cancer medicine in Greece, Cyprus and Malta, to treat patients with HER2 positive locally advanced or metastatic breast cancer.

GENESIS Pharma, a leading regional biopharma company operating in the broader region of South East Europe, announced their exclusive agreement with Jazz Pharmaceuticals, a global biopharmaceutical company dedicated to developing life-changing medicines for serious diseases, for the commercialization of a cancer medicine in Greece, Cyprus and Malta, for the treatment of adults with newly diagnosed, therapy-related acute myeloid leukaemia (t-AML) or AML with myelodysplasia-related changes (AML-MRC).

On this year's World Rare Diseases Day, February 28, a new disease awareness website for the rare genetic disease Fabry is being launched in Greece. The www.fabryfamilytree.gr platform includes information about the disease, its symptoms, its diagnosis and the way it can be passed down the generations of a family. It also includes a very easy-to-use family tree builder application that helps visitors create their family tree and automatically highlights family members who may have a mutation associated with Fabry disease. The data inserted in the family tree builder is completely confidential, accessible only by the individual creating the tree.